Samsung Bioepis

Biogen Ups Investment in Biosimilar Drug Maker Samsung Bioepis by $700 Million
BioSpace
Wed, 11/7/18 - 12:29 pm
Biogen
Samsung Bioepis
biosimilars
Battle Over Humira Begins in Europe as 5-Year Wait Begins in US
RAPS.org
Mon, 10/22/18 - 05:17 pm
Europe
AbbVie
Humira
Amgen
Samsung Bioepis
Mylan Labs
Novartis
Sandoz
Fresenius Kabi
Boehringer Ingelheim
Merck ditches biosimilar Lantus, but will that ease the path for Mylan’s rival insulin product?
Fierce Pharma
Fri, 10/12/18 - 12:47 pm
Merck
Samsung Bioepis
Lantus
insulin
diabetes
biosimilars
Mylan Labs
Biocon
Biogen goes deep into biosimilars, slapping down $700M for a major stake in Samsung Bioepis
Endpoints
Thu, 06/28/18 - 07:08 pm
Biogen
Samsung Bioepis
biosimilars
M&A
Biogen to increase stake in biosimilar developer Samsung Bioepis
Biopharma Dive
Wed, 04/25/18 - 10:25 pm
Biogen
biosimilars
Samsung Bioepis
Janssen drops U.S. lawsuit against Samsung Bioepis' Remicade copy
Yahoo/Reuters
Tue, 11/14/17 - 07:57 am
Janssen
Samsung Bioepis
Remicade
biosimilars
rheumatoid arthritis
Samsung Bioepis first to secure EMA backing for Herceptin biosimilar
BioPharma Dive
Mon, 09/18/17 - 09:23 am
Samsung Bioepis
EMA
Europe
biosimilars
Herceptin
Roche
breast cancer
Biogen, Samsung Humira copy wins EU approval
Fierce Pharma
Fri, 08/25/17 - 09:52 am
Biogen
Samsung Bioepis
Europe
Humira
AbbVie
Imraldi
biosimilars
Samsung Bioepis switches gears, moves from knockoffs to new drugs with fast-changing Takeda
Endpoints
Mon, 08/21/17 - 10:37 am
Samsung Bioepis
Takeda
drug development
TAK-671
pancreatitis
Samsung Bioepis launches a Remicade knockoff at a 35% discount; FDA OK’s a self-administered version of Benlysta
Endpoints
Mon, 07/24/17 - 10:40 am
Samsung Bioepis
Remicade
FDA
biosimilars
JNJ
GSK
Benlysta
lupus
EMA Recommends New HCV, Cancer and MS Drugs for Approval
RAPS.org
Sat, 06/24/17 - 09:11 am
Europe
EMA
hepatitis C
multiple sclerosis
breast cancer
renal cell carcinoma
AbbVie
Maviret
Gilead Sciences
Vosevi
Biogen
Amgen
Samsung Bioepis
biosimilars
Humira
Novartis
Kisqali
EUSA
Fotivda
J&J fires off legal salvo to block Samsung's Remicade biosim launch
Fierce Pharma
Fri, 05/19/17 - 11:30 am
JNJ
Samsung Bioepis
Remicade
biosimilar
Second biosimilar of Remicade approved in the US, but J&J not rattled
BioPharma Dive
Mon, 04/24/17 - 10:02 pm
Remicade
JNJ
biosimilars
Renflexis
Merck
Samsung Bioepis
Hunting growth, Samsung races to get up to speed on biosimilar drugs
Yahoo/Reuters
Tue, 06/7/16 - 11:15 am
Samsung Bioepis
biosimilars
Samsung Bioepis notches European Commission nod for Remicade biosim
Fierce Pharma
Mon, 05/30/16 - 11:05 am
Samsung Bioepis
Europe
Flixabi
Remicade
biosimilars
JNJ
Samsung Bioepis applies for approval to sell Remicade biosimilar in U.S.
Yahoo/Reuters
Mon, 05/23/16 - 09:41 pm
Samsung Bioepis
Remicade
biosimilars
FDA
rheumatoid arthritis
JNJ
Samsung brings in the lawyers for biosimilars push
Yahoo/Reuters
Mon, 04/4/16 - 07:54 am
Samsung Bioepis
AbbVie
biosimilars
Humira
Biogen Inc. Takes Aim at Johnson & Johnson
Motley Fool
Sun, 02/7/16 - 10:45 am
Biogen
JNJ
Samsung Bioepis
Remicade
Amgen Loses Enbrel to Biogen in Europe; Can It Cope?
Bidness, ETC
Tue, 01/19/16 - 10:39 am
Amgen
Biogen
Europe
Enbrel
Samsung Bioepis
biosimilars
Merck and Samsung notch their first biosimilar victory with Enbrel knockoff
Fierce Biotech
Wed, 09/9/15 - 10:42 am
Merck
Samsung Bioepis
Enbrel
biosimilars
Amgen
rheumatoid arthritis

Pages